Practical guidance for IVD and PCR buyers, laboratory teams, and distributors: industry trends, technology explainers, operational playbooks, regulatory context, and procurement education — written for professionals, not for search engines.
7
Published insights
7
Editorial tracks
Source-referenced
Every article carries an evidence trail
Insights
Filtering by Lab Operations
Market shifts, surveillance patterns, regional access changes, and demand signals.
Method explainers for multiplex PCR, extraction, QC, compatibility, and performance basics.
Disease-focused testing guidance connecting scenarios, assays, and workflow decisions.
Workflow efficiency, contamination control, validation planning, and throughput management.
Registration, documentation readiness, tender support, and market access context.
Supplier evaluation, RFQ readiness, TCO comparison, and tender-facing checklists.
Experience-led articles built from implementation, upgrade, and deployment patterns.
Featured Article
A composite case study on MRSA screening: how late reporting happens, the diagnostic decisions that close the gap, and how to verify the fix with measurable targets.
Popular Topics
Method selection, panel breadth, and compatibility trade-offs.
Topic-driven content routes for clinical and screening programs.
Commercial-intent guidance for procurement and distributor teams.
Ready-to-use documents for tenders, verification, and supplier evaluation.
Archive
Size an automated molecular line from demand, not from the catalogue: peak-day modelling, turnaround tiers, and staffing floors for a five-year horizon.
Validation burden grows faster than target count on multiplex panels: cross-reactivity scope, sensitivity balancing, and sample-size planning for rare targets.
Integrated workflow bundles in molecular diagnostics: what consolidation delivers, what it costs in flexibility, and the contract terms that preserve optionality.
